IL33 and inflammatory bowel disease: This divergence, even through use of the same disease agent, points toward IL-33 expression patterns as an important tool for study of the early and late immune response in IBD, suggesting that despite its role in promoting acute inflammation, it may act to limit chronic inflammation in long-term disease.